Mel Schatz

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Sword Diagnostics, Inc. provides next generation detection technology to life scientists. It offers IL-22, IL-1Beta, IL-33, IL-23 and ELISA boosters. The company was founded by David Dingott in 2004 and is headquartered in Summit Argo, IL.

Crux Biomedical, Inc. develops and manufactures medical devices. The company was founded by Thomas Fogarty and Frank Arko in August 2004 and is headquartered in San Diego, CA.

Bacchus Vascular, Inc. manufactures and sells medical devices. It provides treatments for peripheral vascular diseases. The company was founded by Nellix Michael and Thomas J. Fogarthy in 1999 and is headquartered in Santa Clara, CA.

MicroPhage, Inc. provides clinical product development services. The firm develops and markets bacterial identification and antibiotic susceptibility through its bacteriophage-based amplification platform for immunoassay diagnostics. The company was founded by Jack Wheeler and Kent Voorhees in June 2002 and is headquartered in Longmont, CO.

InterVene, Inc. develops non-implantable, catheter-based vein valve creation therapy. Its BlueLeaf endovenous valve formation system allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. The company was founded by Fletcher Wilson in 2011 and is headquartered in South San Francisco, CA.

Brightwater Medical, Inc. develops medical devices. It offers ConvertX Stent, a device that can be converted from a catheter to a nephroureteral stent without a second interventional procedure. The company was founded by Bob Smouse in January 2014 and is headquartered in Temecula, CA.